Department of Regenerative Medicine Research, Texas Heart Institute, Houston, TX.
Am J Transplant. 2014 Nov;14(11):2448-59. doi: 10.1111/ajt.12939. Epub 2014 Oct 7.
Cardiovascular disease (CVD) is the number one cause of death in the United States. However, few treatments for CVD provide a means to regain full cardiac function with no long-term side effects. Novel tissue-engineered products may provide a way to overcome the limitations of current CVD therapies by replacing injured myocardium with functioning tissue or by inducing more constructive forms of endogenous repair. In this review, we discuss some of the factors that should be considered in the development of tissue-engineered products, and we review the methods currently being investigated to generate more effective heart valves, cardiac patches and whole hearts.
心血管疾病 (CVD) 是美国的头号死因。然而,很少有 CVD 治疗方法能够在没有长期副作用的情况下恢复心脏的全部功能。新型组织工程产品可能通过用功能组织替代受损的心肌,或通过诱导更具建设性的内源性修复形式,为克服当前 CVD 治疗方法的局限性提供了一种途径。在这篇综述中,我们讨论了在组织工程产品开发中应考虑的一些因素,并回顾了目前正在研究的生成更有效心脏瓣膜、心脏补片和整个心脏的方法。